(Circulation. 1996;93:1114-1122.)
© 1996 American Heart Association, Inc.
Articles |
Patency of Infarct-Related Artery
Effect of Restoration of Anterograde Flow on Vagal Reflexes
From the Divisione di Cardiologia, Centro Medico di Montescano, Fondazione Clinica del Lavoro, IRCCS (A.M., M.T.L.R.) and the Cattedra di Cardiologia, Dipartimento di Medicina Interna, University of Pavia (Italy), Policlinico S. Matteo, IRCCS (G.S., P.J.S.); the Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY (J.T.B.Jr); the Department of Medicine, University Medical Center, University of Arizona, Tucson (F.I.M.); the Department of Cardiological Sciences, St George Hospital, Medical School, London, UK (J.A.C.); the Department of Cardiology, University Hospital Freiburg (Germany) (S.H.H.); the Third Division of Internal Medicine, Kyoto (Japan) University Hospital, Sakyoku (R.N.); and the Centro di Fisiologia Clinica ed Ipertensione, Istituto di Clinica Medica Generale e Terapia Medica, University of Milan (Italy) (P.J.S.).
Correspondence to Andrea Mortara, MD, Divisione di Cardiologia, Centro Medico di Montescano, 27040 Montescano (Pavia), Italy.
 |
Abstract |
|---|
 Top Abstract IntroductionMethods Results Discussion Appendix References |
|---|
Background In post–myocardial infarction (MI) patients, the restoration of anterograde flow in the infarct-related artery (IRA) significantly improves survival. Limitation of infarct size and increased electrical stability of the myocardium are likely operating mechanisms for this beneficial effect. We tested the hypothesis that patency of the IRA may enhance vagal reflexes, a factor known to affect electrical stability of the infarcted myocardium.
Methods and Results Analysis of angiographic data was performed in 359 of 1284 post-MI patients enrolled in a multicenter prospective study within 8 weeks after the index MI. All the patients underwent baroreflex sensitivity (BRS) assessment by the phenylephrine method. The BRS of the entire population averaged 8.2±5.5 ms/mm Hg and was significantly related to age but not to ejection fraction (EF). One-, two-, and three-vessel disease was present in 138, 96, and 99 patients, respectively, while no coronary stenosis was observed in 26. IRA patency was documented in 234 patients (65%), while in the remaining 125 (35%), the artery remained occluded. Patients with occluded IRAs had more extensive coronary disease (2 to 3 vessels, 71% versus 46%, P<.01) and more depressed left ventricular (LV) function (LVEF, 48±13% versus 53±12%, P<.001). Patency of the IRA was associated with higher BRS values (BRS, 8.9±5.8 versus 7.1±4.7 ms/mm Hg, P<.005) and with a lower incidence (9% versus 18%, P<.02) of markedly depressed BRS (<3 ms/mm Hg), a condition suggested by preliminary studies to be associated with an increased risk of post-MI mortality. The association between IRA patency and BRS was more evident in anterior than in inferior MI. Multivariate regression analysis showed that age of the patient and patency of the IRA were the major independent determinants of BRS, while LVEF was weakly related to BRS and only when analyzed as a categorized variable.
Conclusions The presence of an open IRA is associated with a higher baroreflex sensitivity, and this effect is largely independent of limitation of infarct size by IRA patency. These data offer new insights into the mechanisms by which coronary artery patency may affect cardiac electrical stability and survival.
Key Words: myocardial infarction • reperfusion • angiography • nervous system, autonomic
|
Introduction |
|---|
|
TopAbstractIntroductionMethods Results Discussion Appendix References |
|---|
Thrombolysis and patency of the IRA may be beneficial in improving survival independently of their effect on preservation of left ventricular function.1 2 3 4 Among the mechanisms involved, it has been proposed that an occluded IRA may increase sudden death by reducing the electrical stability of the myocardium.3 5 6 The favorable effect of patency of the IRA on the electrophysiological substrate for ventricular arrhythmias is manifested by a decreased incidence of late potentials on the signal-averaged ECG7 8 9 and by a reduction in QT-interval dispersion.10 Whether IRA patency also has a clear effect on the autonomic modulators of arrhythmogenesis, such as the sympathovagal balance and particularly vagal tone, is uncertain.
In the postinfarction period, a depressed BRS, a marker of depressed
vagal reflexes, is associated with an increased risk of serious
ventricular arrhythmias and subsequent sudden
death.11 12 13 Thrombolytic therapy seems
to
affect baroreceptive reflexes.14 15 However, given
the
early rate of patency after thrombolysis ranging
between 50% and 80%16 and the 
10% occurrence of
reocclusion in the first month,17 it is unwarranted to
draw an inference about the relation between IRA patency and BRS in the
absence of angiographic data. At this time, no data are available on
the influence of the patency of the IRA on BRS.
In 1991, a prospective multicenter study, ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction), was designed to assess the prognostic implications of heart rate variability and of BRS after a recent MI.18 The trial, conducted in 25 centers in Europe, North America, and Japan (see "Appendix"), enrolled 1284 patients and is near conclusion.
The purpose of the present study was to examine, in a large population of patients who had survived an MI, whether a relation exists between patency of the IRA, left ventricular function, and BRS. The underlying hypothesis was that an open IRA would be associated with improved baroreflex control of heart rate.
Preliminary data have been presented.19
|
Methods |
|---|
|
TopAbstractIntroductionMethods Results Discussion Appendix References |
|---|
Study Population
Of 1284 patients with a recent MI enrolled into the ATRAMI multicenter trial between May 1991 and February 1994, 574 patients had coronary angiography. The present analysis was performed on the first 413 sets of data received at the coordinating center. The diagnosis of acute MI was confirmed by serial ECGs and serum enzyme changes in all patients. For the present analysis, coronary angiography, measurement of LVEF, and BRS assessment were required.
Patients were excluded from ATRAMI if they were >80 years old and had at least one of the following criteria: coexisting significant valvular disease or cardiomyopathy, arterial blood pressure of >160/90 mm Hg, insulin-dependent diabetes, unstable angina, atrial fibrillation, or abnormal sinus node function.
Among the patients who underwent angiography, 54 were excluded from the analysis either because angiography was performed more than 8 weeks after MI (n=40) or because the IRA was not detectable (n=14). The final study population consisted of 359 patients. They all gave informed consent, and the study was approved by the local ethical committee of each center.
Coronary Angiography
Cardiac catheterization was performed
according
to the policy and the usual procedure of each center. Clinical data
from the patients who did and who did not undergo coronary
angiography are reported in Table 1
. This table shows
that no significant difference exists between the patients who did and
who did not undergo angiography, with the exception of a slightly lower
LVEF (49% versus 51%) among the patients who did not receive
angiography. This argues against the possibility of a selection bias in
the population examined here, a factor that would have prevented the
extrapolation of the results to the general post-MI population. A
significant coronary artery stenosis was defined as a
70% decrease in luminal diameter in one, two, or three of the major
coronary branches. A closed IRA was defined as a complete
occlusion; a patent IRA was defined as one with stenosis but
not complete occlusion. The IRA was identified by assessment of the
ECGs, the ventriculographic location of contractile abnormality, and
the presence of obstruction in the corresponding artery.16
The status of the infarct-related vessels was determined by two
investigators (A.M. and G.S.) without knowledge of the BRS values of
the individual patients. LVEF was calculated from the 30° right
anterior oblique ventriculogram by a standard area-length method;
in the patients without angiography, it was calculated by
echocardiography.
|
BRS Assessment
Arterial baroreceptor function was evaluated
by the
administration of a vasoactive drug, phenylephrine,
according to the method proposed by Smyth et al.20 BRS
studies were performed with the same technique in all ATRAMI centers
and were centrally analyzed in Montescano by two independent
and experienced observers (M.T.L.R. and A.M.), as previously
described.12 Briefly, one ECG lead and systolic
arterial pressure obtained either directly from the
radial/brachial artery or noninvasively by Finapres (Ohmeda) were
continuously recorded and digitally converted in a personal
computer system. The invasive and noninvasive methods provide highly
correlated (r=.92) BRS values.21 When heart
rate and blood pressure were stable, an intravenous bolus
of phenylephrine HCl (Neo-Synephrine, Winthrop
Laboratories, 2 µg/kg) was given to raise the systolic
arterial pressure by 15 to 40 mm Hg. If blood pressure did
not increase as desired, additional injections were made, increasing
the dosage of phenylephrine by increments of 25 to 50 µg.
The bolus injection was repeated at least three times at the dosage
found to induce the required blood pressure increase and at not less
than 10-minute intervals. The RR intervals were plotted against the
preceding arterial pulse, and a linear regression
analysis was performed for those points included between
the beginning and the end of the first significant increase in
systolic arterial pressure. Only regression lines
with a statistically significant correlation coefficient
(P<.05) were accepted for analysis. A final slope
was usually obtained by calculating the mean value of at least three
determinations. This value was then considered as
representing BRS (ms/mm Hg).
BRS was assessed at a mean of 17±7 days (range, 5 to 35 days) after MI. As previously suggested,12 we considered a BRS value <3.0 ms/mm Hg to be a markedly depressed BRS.
Statistical Analysis
Results are expressed as mean±SD.
Statistical significance was
defined at a value of P<.05. One-way ANOVA for
continuous measures and the 
2 test for
categorical variables were used to assess the correlation with
patent or occluded IRA. Because of the skewed distribution of BRS,
Wilcoxon signed-rank test and Kruskal-Wallis ANOVA were
used when appropriate, and Spearman's rank correlation procedure was
used to determine the correlation of BRS with other clinical
variables. Stepwise regression analysis was performed with
the natural logarithm of BRS slope as a dependent variable to
determine the most important predictors of differences in BRS.
|
Results |
|---|
|
TopAbstractIntroductionMethods Results Discussion Appendix References |
|---|
Patient Characteristics
The mean age of the final study group (n=359) was 56±11 years (range, 21 to 79 years); 89% were men. Thrombolytic therapy, either streptokinase or tissue-type plasminogen activator, was administered to 206 patients (57%); of the entire population, 24% were on ß-blockers. The site of infarction was anterior in 191 patients (53%) and inferior in 168 (47%), while 21% had non–Q-wave MI. The mean LVEF was 51±12% (range, 20% to 79%).
Baroreflex Sensitivity
No adverse effects were observed
during or after the
phenylephrine injections. The BRS of the entire population
was 8.2±5.5 ms/mm Hg (range, 0.1 to 37.5 ms/mm Hg; median, 7.3 ms/mm
Hg); no relation was found between BRS and the time elapsed between MI
and BRS determination (r=-.10) (Fig 1).
As previously reported,12 22 BRS was significantly
related
to age (r=-.52, P<.001) (Fig
2) but not to ejection fraction (r=.16) (Fig
3A) or to left ventricular
end-systolic volume (r=.10), even though
patients with the lowest ejection fraction (
30%) had a more
depressed BRS (Fig 3B). Patients with non–Q-wave MI had a
higher BRS
than those with Q-wave MI (9.0±5.6 versus 7.9±5.8 ms/mm Hg,
P<.05).
|
|
|
Coronary Angiography
Coronary angiography was performed a
mean of 26±35 days
(range, 0 to 60 days) after MI. Clinical characteristics of patients
who had early (0 to 7 days) versus late (8 to 60 days) coronary
angiography were not significantly different (Table 2).
|
One-vessel disease was present in 138 patients (38%),
two-vessel disease in 96 (27%), and three-vessel disease in 99
(28%); no significant coronary stenosis was observed
in 26 patients (7%). The extent of coronary disease was not
related to age; indeed, when age was divided into four percentiles, the
incidence of two- and three-vessel disease was found to be similar
in all four groups (49 years, 23%; 50 to 57 years, 32%; 58 to 64
years, 25%; and >65 years, 28%). At the time of coronary
angiography, 234 patients (65%) had a patent IRA and 125 (35%) a
closed IRA. Comparison of clinical and angiographic data between
patients with patent and occluded IRAs is reported in Table 3.
Thrombolysis had been used more
frequently in patients with a patent IRA, but despite therapy, 66
(30%) of the patients who received thrombolysis showed
an occluded vessel, whereas 65 (47%) who did not receive
thrombolysis had an open IRA. As expected, patency of
the IRA was associated with less extensive severity of coronary
disease (see Table 3). These results were not influenced by the
sequence or time elapsed between the BRS study and cardiac
catheterization (the most common temporal sequence),
which was similar in patients with patent and closed IRAs (5.6±24
versus 6.7±27 days, P=.7).
|
Relation Between BRS, Arterial Patency, and Left
Ventricular Function
BRS was not significantly different in patients
who had early
versus late cardiac catheterization (Table 2
). There is
a trend toward a more depressed BRS in patients with multivessel
disease. Patients with occluded IRAs had a more depressed
ventricular function (LVEF, 48±13% versus 53±12%,
P<.001) and a lower BRS (7.1±4.7 versus 8.9±5.8
ms/mm Hg,
P<.005) compared with patients with patent IRAs (Table
3).
This relation between BRS and patency of the IRA persists also when the
number of stenotic vessels (Fig 4) and the
severity of ventricular dysfunction are considered, with
the exception of the group with the most depressed LVEF (Fig
5).
|
|
There was no correlation between BRS and the
location of the vessel
involved, ie, right or left coronary artery. However, patency
of the IRA was associated with a higher BRS in anterior than in
inferior MI (anterior MI: open artery, 9.3±5 versus closed
artery, 6.2±3 ms/mm Hg, P=.001; inferior MI:
open artery, 8.9±6 versus closed artery, 7.9±5 ms/mm Hg,
P=.03). This site-dependent differential effect of IRA
patency on BRS was not evident on LVEF, which was higher to a similar
degree in all patients with patent IRAs independently of the location
of MI (Table 4).
|
The distribution of patients with BRS
<3 ms/mm Hg was calculated
according to patent or occluded IRA because this cutoff value had
previously been found to be associated with higher
mortality.12 13 Fig 6 documents the
significantly lower incidence of markedly depressed BRS in patients
with patent IRAs (9.4% versus 17.6%, 2=5.3,
P<.02).
|
Six clinical and angiographic variables, including
age, LVEF
(analyzed both as a continuous variable and also as
categorized into four classes: 30%, 31% to 40%, 41% to 50%, and
>50%), extent of coronary artery disease, site of MI, time
between MI and BRS determination, and patency of the IRA, were entered
into a stepwise multiple regression analysis with BRS as a
dependent variable. Age of the patient and patency of the IRA
emerged as significant independent predictors of BRS (Table 5).
LVEF was significantly associated with BRS only when
it was entered into the regression analysis as a categorized
variable but not when it was analyzed as a continuous
variable (Table 5), which indicates a weak association.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethods Results Discussion Appendix References |
|---|
The present results indicate that, largely independently of ventricular function, restoration of anterograde flow in the infarct-related vessel is associated with a higher BRS, a marker of vagal activity that appears to have prognostic value for post-MI patients.18 These data also suggest that sustained patency of the IRA is beneficial not only by limiting infarct size but also by improving cardiac electrical stability through a specific autonomic modulation.
BRS and MI
Electrical stability of the myocardium is largely
influenced by the balance between the sympathetic and parasympathetic
components of the autonomic nervous system.23 24
Vagal
activation, largely through the sympathetic-parasympathetic
antagonism,25 opposes most of the arrhythmogenic
influences mediated by the release of
catecholamines.26 Moreover, there is now
strong evidence for an antifibrillatory effect of vagal activation
produced either by direct electrical stimulation,27 by
pharmacological activation of muscarinic receptors,28 or
by exercise training.29 30 MI can modify the
autonomic
balance by decreasing vagal tone and reflexes,11 as shown
by the depression in heart rate variability and in BRS so often
observed after an MI.31 32
Experimental11 and
clinical12 13 studies have shown that a depressed BRS
in
the post-MI period represents a marker of increased risk for
life-threatening arrhythmias and for sudden death.
The mechanism by which BRS is reduced after MI remains speculative. BRS decreases whenever the autonomic balance shifts toward a sympathetic dominance. MI, by impairing myocardial contractility and stroke volume, may produce changes both in arterial pressure and in the rate of ejection, which are sensed by baroreceptors and thus influence autonomic responses.33 Another possible mechanism involves the changes in the geometry of a beating heart secondary to the presence of necrotic and noncontracting segments, which may increase the firing of sympathetic afferent fibers beyond normal by mechanical distortion of their sensory endings.34 This excitation of cardiac sympathetic afferent fibers impairs the baroreceptor reflex and has an inhibitory effect on vagal activity directed to the heart.35 36 37 In addition, experimental and clinical data indicate that an MI alters both afferent and efferent cardiac innervation, thus disrupting or modifying the afferent activity originating from ventricular mechanoreceptors.38
Since the derangement in neural activity of cardiac origin is likely to be a major cause of increased sympathetic activity after MI, it would be logical to assume that the larger the infarct size, the lower the baroreflex function. As a matter of fact, data exist to support this concept. In the animal model for sudden death that demonstrated the relation between depressed BRS and risk of ventricular fibrillation during an ischemic episode,11 an analysis was performed on the relation between infarct size (in percentage of the left ventricle), BRS, and survival. It was found that large infarcts were more frequently associated with very depressed BRS and that only in the presence of this association did the risk of sudden death increase sharply, which suggests that autonomic triggers acquire special relevance in the presence of an arrhythmogenic substrate.39 This is consistent with our present finding of more depressed BRS in patients with more severe ventricular dysfunction. Nevertheless, BRS should not be considered merely an index of the status of ventricular function, as demonstrated by the fact that no linear correlation has been found between LVEF and BRS slope in several studies,12 13 including the present one. Admittedly, LVEF could be an imperfect measure of ventricular performance because it is load-dependent; however, similar results have also been obtained by use of different indexes of ventricular function, such as peak positive dP/dt, dP/dt/P, end-diastolic pressure, and mean systolic ejection rate.40 Finally, no correlation was found in the present study between BRS and left ventricular end-systolic volume.
Coronary Artery Patency, BRS, and Cardiac Electrical
Stability
Reperfusion of the IRA significantly and independently
increases
survival. This effect, documented in small angiographic
studies41 42 and in large trials with
thrombolytic agents,16 43 44 seems to be
independent of the limitation in infarct
size.1 2 3 43 It
has been suggested that other mechanisms, such as a more favorable left
ventricular remodeling,45 a "scaffolding
effect" by the blood-filled coronary vascular bed
perfusing the necrotic myocardium,3 and/or a
reduction in the incidence of malignant
arrhythmias,5 6 may be involved.
As to the relation between an open IRA and cardiac electrical stability, there is evidence that thrombolytic therapy reduces the incidence of ventricular fibrillation,46 inducible ventricular tachycardia,47 48 and arrhythmic events.49 Life-threatening arrhythmias in post-MI patients are facilitated by the interaction between an abnormal substrate and an autonomic imbalance characterized by either decreased vagal or increased sympathetic activity.18 Reperfusion has a favorable effect on the incidence of late potentials,7 8 9 49 thus reducing one substrate for ventricular reentry. At variance with the growing knowledge on the relation between a patent IRA and the anatomic substrates for cardiac arrhythmias, very little is known about the potential relation between a patent IRA and the autonomic nervous system, particularly in reference to vagal reflexes. The present data show that IRA patency is closely related to BRS, a marker of the capability of reflexly increasing vagal activity. Of special clinical relevance is the fact that IRA patency seems to significantly increase the mean BRS value and to reduce the incidence of patients with markedly depressed BRS, who are at higher risk of arrhythmic events.
The effect of IRA patency on BRS seems to be largely independent of LVEF. Several arguments militate in favor of this concept. The first is the very weak correlation between BRS and LVEF. The second and major one is that multivariate analysis identified age and patency of the IRA as major independent determinants of BRS but not LVEF, with the exception of when it was analyzed as a categorized variable. Finally, even in the last case, patency of the IRA maintained its high independent value as a determinant of BRS.
The present study contributes to clarification of the question of a presumed relation between BRS and infarct site. In the first clinical study published,12 based on 78 patients, it was reported that BRS was lower in patients with an inferior MI. Not surprisingly, the finding was confirmed in a subset of the same population.50 Subsequently, in a population of 122 patients, no difference was found between anterior and inferior MI.13 The present data, based on 359 patients, indicate no significant difference. Overall, it seems that the initial findings were probably dependent on the small size of the population under study.
When the IRA was patent, the greatest effect on BRS was observed in the patients with an anterior MI. If the hypothesis is correct that a patent-IRA–dependent improvement in BRS may favorably affect cardiac electrical stability, then one would expect improved survival particularly in the group of patients with patent IRA and anterior MI. This seems indeed to be the case, according to a report that IRA patency markedly influences long-term survival, especially in patients with the left anterior descending or the left circumflex coronary artery as culprit vessel.41
Even though the study was not designed to investigate the mechanisms underlying the relation between IRA patency and BRS, a few tenable hypotheses exist. Namely, IRA patency may affect BRS (1) by causing a more favorable remodeling in the ventricular walls3 45 and producing both a "scaffolding" effect, which supports the surrounding necrotic myocardium, and areas of hibernating myocardium, which limit ventricular dilatation and aneurysm formation3 6 51 ; (2) by improving ventricular function, which stimulates baroreceptors via an increased stroke volume; and (3) at neurohormonal levels, by reducing plasma concentration of norepinephrine and especially of angiotensin II,52 which affects BRS directly in the vasomotor and cardiac centers in the brain.53 However, it is likely that more than one of these mechanisms may be operant in the same patient.
As to the relation between successful reperfusion and autonomic activity, the present data are in agreement with previous reports based on the analysis of heart rate variability.54 55 Hermosillo et al54 observed an increase of all components of the heart rate variability power spectrum in patients with patent IRAs, particularly in the high-frequency band, which largely reflects vagal tone. Similarly, Odemuyiwa et al,55 using another index of heart rate variability, found that the status of the IRA favorably influenced the autonomic balance. Our own results provide novel information because BRS and heart rate variability, even if they are probably interrelated,56 are very different measures of vagal activity and are not redundant.50 57
In conclusion, we suggest that sustained anterograde flow in the IRA attenuates the detrimental effect of MI on vagal reflexes, thus probably contributing to increased cardiac electrical stability.
|
Selected Abbreviations and Acronyms |
|---|
|
|
Acknowledgments |
|---|
The authors are especially grateful for the technical support, throughout the study, by GianDomenico Pinna, BME, and Giovanni Corsico, BMT, of the Biomedical Engineering Department of the Centro Medico di Montescano.
|
Appendix |
|---|
|
TopAbstractIntroductionMethods Results Discussion Appendix References |
|---|
The following centers and investigators participated in the ATRAMI study. The principal investigators are denoted by an asterisk. Numbers in parentheses are the number of enrolled patients for each center.
Italy: Centro Medico di Montescano, Pavia (M.T. La Rovere,* A. Mortara, P. Pantaleo) (101); Università di Milano, Istituto di Clinica Medica II (P.J. Schwartz,* E. Vanoli) and Policlinico di Milano (A. Lotto,* G. De Ferrari) (64); Centro Medico di Tradate, Varese (R. Tramarin,* R. Pedretti, E. Colombo) (86); Ospedale di S. Donato, Milano (L. de Ambroggi,* A. Caporotondi) (54); Ospedale Maggiore di Milano (C. de Vita,* G. Cataldo, M. Tavanelli) (24); Ospedale "V. Cervello," Palermo (E. Geraci,* S. Grasso, A. Canonico) (88); Istituto di Fisiologia Clinica CNR, Pisa (A. L'Abbate,* C. Carpeggiani) (31); Centro Medico di Veruno, Novara (G. Mazzuero,* P. Lanfranchi) (65); Policlinico "S. Matteo," Pavia (G. Specchia,* A. Mussini) (48); Ospedale "Careggi," Firenze (P.F. Fazzini,* G.M. Santoro, P.G. Buonamici) (62); Ospedale Civile "Umberto I," Venezia-Mestre (E. Piccolo,* A. Raviele, L. Corò) (11); Ospedale Consorziale-Policlinico di Bari (P. Rizzon,* A. Bortone, N. Di Venere) and Centro Medico di Cassano Murge, Bari (F. Mastropasqua) (53); Ospedale Maggiore di Lodi (M. Orlandi,* S. Belletti, G.F. Galloni) (28); Ospedale Civile di Alessandria (P.A. Ravazzi,* F. Provera, M.C. Ferrara) (11); Ospedale Maggiore, Varese (G. Binaghi,* F. Forgione, E. Castaldo) (9); Ospedale di Rovereto, Trento (M. Disertori,* M.T. Della Mea, M. DelGreco) (31).
France: Hôpital Central, Nancy (E. Aliot,* N. Sadoul, P. Simon, C. De Chillou) (41).
Germany: Westfälische Wilhelms-Universität Münster (G. Breithardt,* M. Block, T. Fetsch, D. Bocker) (23); Albert Ludwigs University Hospital, Freiburg (S. Hohnloser,* M. Zabel) (150).
United Kingdom: St Georges Hospital, London (J. Camm,* M. Malik, A. Staunton) (150).
United States: College of Physicians and Surgeons, Columbia University, New York, NY (J.T. Bigger, Jr,* D. Bloomfield) (19); Health Sciences Center, University of Arizona, Tucson (F.I. Marcus,* C. Furman, K. Gear) (13); Memorial Hospital, Oklahoma City, Oklahoma (R. Lazzara,* S. Harris, T.L. Deaton) (11); Strong Memorial Hospital, University of Rochester, Rochester, NY (Chang sen Liang,* J. Delehanty) (5).
Japan: Kyoto University Hospital, Sakyoku, Kyoto City (R. Nohara) (106).
Steering Committee: P.J. Schwartz, Pavia, Italy (Chairman); J.T. Bigger, Jr, New York, NY; M.T. La Rovere, Montescano, Pavia, Italy; F.I. Marcus, Tucson, Ariz.
Events Committee: F.I. Marcus, Tucson, Ariz (Chairman); S. Hohnloser, Freiburg, Germany; G. Specchia, Pavia, Italy.
Data Coordinating Center: Centro Medico di Montescano, Pavia, Italy: M.T. La Rovere, A. Mortara.
Technical Support: G.D. Pinna (Coordinator); G. Corsico, Department of Biomedical Engineering, Centro Medico di Montescano, Pavia, Italy.
Administrative Coordination: Fondazione Clinica del Lavoro, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Centro Medico di Montescano, Pavia, Italy.
Received July 24, 1995; revision received October 16, 1995; accepted October 18, 1995.
|
References |
|---|
|
TopAbstractIntroductionMethods Results Discussion Appendix References |
|---|
1. Van de Werf F. Discrepancies between the effects of coronary reperfusion on survival and left ventricular ejection fraction. Lancet. 1989;1:1367-1369. [Medline] [Order article via Infotrieve]
2. Califf RM, Topol EJ, Gersh BJ. From myocardial salvage to patient salvage in acute myocardial infarction: the role of reperfusion therapy. J Am Coll Cardiol. 1989;14:1382-1388. [Medline] [Order article via Infotrieve]
3.
Braunwald E. Myocardial reperfusion, limitation
of infarct size, reduction of left ventricular dysfunction
and improved survival: should the paradigm be expanded?
Circulation. 1989;79:441-444.
4.
White HD, Cross DB, Elliott JM, Norris RM, Yee
TW. Long-term prognostic importance of patency of the
infarct-related coronary artery after
thrombolytic therapy for acute myocardial
infarction. Circulation. 1994;89:61-67.
5. Ambrose JA. The open artery: beyond myocardial salvage. Am J Cardiol. 1993;72:85G-90G. [Medline] [Order article via Infotrieve]
6.
Kim CB, Braunwald E. Potential benefits of late
reperfusion of infarcted myocardium: the open artery
hypothesis. Circulation. 1993;88:2426-2436.
7. Gang ES, Lew AS, Hong M, Wang FZ, Siebert CA, Peter T. Decreased incidence of ventricular late potentials after successful thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1989;321:712-716. [Abstract]
8. Lange RA, Cigarroa RG, Wells PJ, Kremers MS, Hillis LA. Influence of anterograde flow in the infarct artery in the incidence of late potentials after acute myocardial infarction. Am J Cardiol. 1990;65:554-558. [Medline] [Order article via Infotrieve]
9. Vatterott PJ, Hammil SC, Bailey KR, Wiltgen CM, Gersh BJ. Late potentials on signal-averaged electrocardiograms and patency of the infarct related artery in survivors of acute myocardial infarction. J Am Coll Cardiol. 1991;17:330-337. [Abstract]
10.
Moreno FL, Villanueva MT, Karagounis LA, Anderson JL,
for the Team-2 Study Investigators. Reduction in QT interval dispersion
by successful thrombolytic therapy in acute myocardial
infarction. Circulation. 1994;90:94-100.
11.
Schwartz PJ, Vanoli E, Stramba Badiale M, De Ferrari
GM, Billman G, Foreman DR. Autonomic mechanisms and sudden
death: new insights from analysis of baroreceptor reflexes in
conscious dogs with and without a myocardial infarction.
Circulation. 1988;78:969-979.
12.
La Rovere MT, Specchia G, Mortara A, Schwartz
PJ. Baroreflex sensitivity, clinical correlates and
cardiovascular mortality among patients with a first
myocardial infarction: a prospective study.
Circulation. 1988;78:816-824.
13.
Farrell TG, Odemuyiwa O, Bashir Y, Cripps TR, Malik M,
Ward DE, Camm AJ. Prognostic value of baroreflex sensitivity
testing after acute myocardial infarction. Br Heart
J. 1992;67:129-137.
14. Odemuyiwa O, Farrell TG, Staunton A, Sheddon J, Poloniecki J, Bennett D, Malik M, Camm AJ. Influence of thrombolytic therapy on the evolution of baroreflex sensitivity after myocardial infarction. Am Heart J. 1993;125:285-291. [Medline] [Order article via Infotrieve]
15.
La Rovere MT, Mortara A, Bigger JT Jr, Marcus FI,
Hohnloser SH, Nohara R, Camm AJ, Schwartz PJ, on behalf of the ATRAMI
Investigators. Effect of thrombolytic therapy on
baroreceptors reflexes. Eur Heart J. 1994;15:446. Abstract.
16.
GUSTO Angiographic Investigators. The effect of tissue
plasminogen activator, streptokinase or both on
coronary artery patency, ventricular function and
survival after acute myocardial infarction. N Engl J
Med. 1993;329:1615-1622.
17.
Ohman EM, Califf RM, Topol EJ, Candela RJ, Ellis SG,
Sigmon KN, Kereiakes DJ, George BB, Stack RS, and TAMI Study Group.
Consequences of reocclusion following successful reperfusion therapy in
acute myocardial infarction. Circulation. 1990;82:781-791.
18. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death: experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation. 1992;82(suppl I):I-77-I-91.
19. Mortara A, La Rovere MT, Specchia G, Bigger JT Jr, Marcus FI, Schwartz PJ, on behalf of the ATRAMI Investigators. An open infarct-related artery influences baroreflex sensitivity, a marker of autonomic balance. J Am Coll Cardiol. 1994:148A. Abstract.
20.
Smyth HS, Sleight P, Pickering GW. Reflex
regulation of arterial pressure during sleep in man: a
quantitative method of assessing baroreflex sensitivity.
Circ Res. 1969;24:109-121.
21. La Rovere MT, Mortara A, Bigger JT Jr, Marcus FI, Buonamici PG, Colombo E, Grasso S, Hohnloser SH, Nohara R, Schwartz PJ, for the ATRAMI Investigators. Reliability of non-invasive measurement of baroreflex sensitivity after myocardial infarction: ATRAMI, an international multicenter prospective study. Eur Heart J. 1993;14:253. Abstract.
22.
Gribbin B, Pickering TG, Sleight P, Peto R.
Effect of age and high blood pressure on baroreflex sensitivity in
man. Circ Res. 1971;29:424-431.
23. Schwartz PJ, Priori SG. Sympathetic nervous system and cardiac arrhythmias. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, Pa: WB Saunders Co; 1990:330-343.
24. De Ferrari GM, Vanoli E, Schwartz PJ. Cardiac vagal activity, myocardial ischemia and sudden death. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1994:422-434.
25.
Levi MN. Sympathetic-parasympathetic
interactions in the heart. Circ Res. 1971;29:437-445.
26. Levi MN, Schwartz PJ, eds. Vagal Control of the Heart: Experimental Basis and Clinical Implications. Armonk, NY: Futura Publishing Co; 1994:644.
27.
Vanoli E, De Ferrari GM, Stramba Badiale M, Hull SS Jr,
Foreman RD, Schwartz PJ. Vagal stimulation and prevention of
sudden death in conscious dogs with a healed myocardial
infarction. Circ Res. 1991;68:1471-1481.
28. De Ferrari GM, Salvati P, Grossoni M, Ukmar G, Vaga L, Patrono C, Schwartz PJ. Pharmacological modulation of the autonomic nervous system in the prevention of sudden cardiac death. J Am Coll Cardiol. 1993;22:283-290. [Abstract]
29.
Billman GE, Schwartz PJ, Stone HL. The effect of
daily exercise on susceptibility to sudden cardiac death.
Circulation. 1984;69:1182-1189.
30.
Hull SS Jr, Vanoli E, Adamson PB, Verrier RL, Foreman
RD, Schwartz PJ. Exercise training confers anticipatory
protection from sudden death during acute myocardial
ischemia. Circulation. 1994;89:548-552.
31. Schwartz PJ, Zaza A, Pala M, Locati E, Beria G, Zanchetti A. Baroreflex sensitivity and its evolution during the first year after a myocardial infarction. J Am Coll Cardiol. 1988;12:629-636. [Abstract]
32. Lombardi F, Sandrone G, Pernpruner S, Sala R, Garimoldi M, Cerutti S, Baselli G, Pagani M, Malliani A. Heart rate variability as an index of sympathovagal interactions after acute myocardial infarction. Am J Cardiol. 1987;60:1239-1245. [Medline] [Order article via Infotrieve]
33. Eckberg DL, Sleight P, eds. Human Baroreflexes in Health and Disease. Oxford, UK: Clarendon Press; 1992:351-366.
34.
Malliani A, Recordati G, Schwartz PJ.
Nervous activity of afferent cardiac sympathetic fibers with atrial and
ventricular endings. J
Physiol. 1973;229:457-469.
35. Schwartz PJ, Pagani M, Lombardi F, Malliani A, Brown AM. A cardio-cardiac sympathovagal reflex in the cat. Circ Res. 1973;72:215-220.
36.
Gnecchi Ruscone T, Lombardi F, Malfatto G, Malliani
A. Attenuation of baroreceptive mechanisms by
cardiovascular sympathetic afferent fibers.
Am J Physiol. 1987;253:H787-H791.
37.
Cerati D, Schwartz PJ. Single cardiac vagal
fiber activity, acute myocardial ischemia, and risk for sudden
death. Circ Res. 1991;69:1389-1401.
38.
Zipes DP. Influence of myocardial
ischemia and infarction on autonomic innervation of the
heart. Circulation. 1990;82:1095-1105.
39. Schwartz PJ. An experimental approach to the problem of post-infarction angina and sudden cardiac death. Eur Heart J. 1986;7(suppl C):7-17.
40. La Rovere MT, Mortara A, Ghio S, Specchia G, Schwartz PJ. Baroreflex sensitivity and left ventricular function in post-myocardial infarction patients. Circulation. 1987;76(suppl IV):IV-59. Abstract.
41. Cigarroa RG, Lange RA, Hillis LD. Prognosis after acute myocardial infarction in patients with and without residual anterograde coronary blood flow. Am J Cardiol. 1989;64:155-160. [Medline] [Order article via Infotrieve]
42.
Trappe HJ, Lichtlen PR, Klein H, Wenzlaff P, Hartwing
CA. Natural history of single vessel disease: risk of sudden
coronary death in relation to coronary anatomy
and arrhythmia profile. Eur Heart J. 1989;10:514-521.
43. Kennedy JW, Ritchie JL, Davies KB, Stadius ML, Maynard C, Friz JK. The Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction: a 12 month follow-up report. N Engl J Med. 1985;312:932-936. [Medline] [Order article via Infotrieve]
44. Dalen JE, Gore JM, Braunwald E, Borer J, Goldberg RJ, Passamani ER, Forman S, Knatterud G, and the TIMI Investigators. Six-and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) Trial. Am J Cardiol. 1988;62:179-185. [Medline] [Order article via Infotrieve]
45. Marino P, Zanolla L, Zardini P. Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI Trial. J Am Coll Cardiol. 1989;14:1149-1158. [Abstract]
46. Leung WH, Lau CP. Effects of severity of the residual stenosis of the infarct-related coronary artery on left ventricular dilatation and function after myocardial infarction. J Am Coll Cardiol. 1992;20:307-313. [Abstract]
47. Vermeer F, Simoons ML, Lubsen J. Reduced frequency of ventricular fibrillation after early thrombolysis in myocardial infarction. Lancet. 1986;1:1147-1148.
48. Kersschot IE, Brugada P, Ramentol M, Zehender M, Waldecker B, Stevenson WJ, Geibel A, DeZwaan C, Wellens HJ. Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: a prospective, randomized trial. J Am Coll Cardiol. 1986;7:1234-1242. [Abstract]
49.
Hohnloser SH, Franck P, Klingenheben T, Zabel M, Just
H. Open infarct related artery, late potentials, and other
prognostic factors in patients after acute myocardial infarction in the
thrombolytic era: a prospective trial.
Circulation. 1994;90:1747-1756.
50. Bigger JT Jr, La Rovere MT, Steinman RC, Fleiss JL, Rottman JN, Rolnitzky LM, Schwartz PJ. Comparison of baroreflex sensitivity and heart period variability after myocardial infarction. J Am Coll Cardiol. 1989;14:1511-1518. [Abstract]
51. Touchstone DA, Beller GA, Nygaard TW, Tedesco C, Kaul S. Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in humans: a tomographic assessment using two-dimensional echocardiography. J Am Coll Cardiol. 1989;13:1506-1513. [Abstract]
52. Sigurdsson A, Held P, Swedberg K. Short- and long-term neurohormonal activation following acute myocardial infarction. Am Heart J. 1993;126:1068-1076. [Medline] [Order article via Infotrieve]
53. Scroop GC, Whelan RF. A central vasomotor action of angiotensin in man. Clin Sci. 1966;30:79-90. [Medline] [Order article via Infotrieve]
54. Hermosillo AG, Dorado M, Casanova JM, Ponce de Leon S, Cossio J, Kersenovich S, Colin L, Iturralde P. Influence of infarct-related artery patency on the indexes of parasympathetic activity and prevalence of late potentials in survivors of acute myocardial infarction. J Am Coll Cardiol. 1993;22:695-706. [Abstract]
55. Odemuyiwa O, Jordaan P, Malik M, Farrel T, Staunton A, Poloniecki J, Ward D, Camm J. Autonomic correlates of late infarct related artery patency after first myocardial infarction. Am Heart J. 1993;125:1597-1600. [Medline] [Order article via Infotrieve]
56. Sleight P, La Rovere MT, Mortara A, Pinna G, Maestri R, Leuzzi S, Bianchini G, Tavazzi L, Bernardi L. Physiology and pathophysiology of heart rate and blood pressure variability in humans: is power spectral analysis largely an index of baroreflex gain? Clin Sci. 1995;88:103-109. [Medline] [Order article via Infotrieve]
57.
Hohnloser SH, Klingenheben T, van de Loo A, Hablavetz
E, Just H, Schwartz PJ. Reflexes versus tonic vagal activity as
a prognostic parameter in patients with sustained
ventricular tachycardia or
ventricular fibrillation.
Circulation. 1994;89:1068-1073.
This article has been cited by other articles:
 |
|
 |
|
  A. Bauer, J. Mehilli, P. Barthel, A. Muller, A. Kastrati, K. Ulm, A. Schomig, M. Malik, and G. Schmidt Impact of Myocardial Salvage Assessed by 99mTc-Sestamibi Scintigraphy on Cardiac Autonomic Function in Patients Undergoing Mechanical Reperfusion Therapy for Acute Myocardial Infarction J. Am. Coll. Cardiol. Img., April 1, 2009; 2(4): 449 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Hohnloser Ventricular Arrhythmias: Antiadrenergic Therapy for the Patient with Coronary Artery Disease Journal of Cardiovascular Pharmacology and Therapeutics, October 1, 2005; 10(4_suppl): S23 - S31. [Abstract] [PDF]
|
|
|
|
 |
|
 N G Bellenger, Z Yousef, K Rajappan, M S Marber, and D J Pennell Infarct zone viability influences ventricular remodelling after late recanalisation of an occluded infarct related artery Heart, April 1, 2005; 91(4): 478 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bibevski and M. E. Dunlap Prevention of diminished parasympathetic control of the heart in experimental heart failure Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1780 - H1785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Bonnemeier, U. K.H. Wiegand, J. Friedlbinder, S. Schulenburg, F. Hartmann, F. Bode, H. A. Katus, and G. Richardt Reflex Cardiac Activity in Ischemia and Reperfusion: Heart Rate Turbulence in Patients Undergoing Direct Percutaneous Coronary Intervention for Acute Myocardial Infarction Circulation, August 26, 2003; 108(8): 958 - 964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Piccirillo, M. Nocco, A. Moise, M. Lionetti, C. Naso, S. di Carlo, and V. Marigliano Influence of Vitamin C on Baroreflex Sensitivity in Chronic Heart Failure Hypertension, June 1, 2003; 41(6): 1240 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. G. Robinson, S. L. Dawson, P. J. Eames, R. B. Panerai, J. F. Potter, and S. Oppenheimer Cardiac Baroreceptor Sensitivity Predicts Long-Term Outcome After Acute Ischemic Stroke * Editorial Comment Stroke, March 1, 2003; 34(3): 705 - 712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Hohnloser and B. J. Gersh Changing Late Prognosis of Acute Myocardial Infarction: Impact on Management of Ventricular Arrhythmias in the Era of Reperfusion and the Implantable Cardioverter-Defibrillator Circulation, February 25, 2003; 107(7): 941 - 946. [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Ueno, T. Hamada, and T. Moritani Cardiac Autonomic Nervous Activities and Cardiorespiratory Fitness in Older Men J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2002; 57(9): M605 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Ferrara, F Mastrorilli, G Pasanisi, S Censi, N D'aiello, A Fucili, M Valgimigli, and R Ferrari Neurohormonal modulation in chronic heart failure Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D3 - D11. [Abstract] [PDF]
|
|
|
|
 |
|
 M. E. Pfusterer, P. Buser, S. Osswald, P. Weiss, J. Bremerich, and F. Burkart Time dependence of left ventricular recovery after delayed recanalization of an occluded infarct-related coronary artery: findings of a pilot study J. Am. Coll. Cardiol., July 1, 1998; 32(1): 97 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Pitzalis, F. Mastropasqua, A. Passantino, F. Massari, L. Ligurgo, C. Forleo, C. Balducci, F. Lombardi, and P. Rizzon Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post–Myocardial Infarction Patients Circulation, April 14, 1998; 97(14): 1362 - 1367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mortara, M. T. La Rovere, G. D. Pinna, A. Prpa, R. Maestri, O. Febo, M. Pozzoli, C. Opasich, and L. Tavazzi Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure : Clinical and Hemodynamic Correlates and Prognostic Implications Circulation, November 18, 1997; 96(10): 3450 - 3458. [Abstract] [Full Text]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||